Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Moore Kuehn, PLLC Encourages Investors of Nektar Therapeutics to Contact Law Firm

PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
December 29, 2022 GMT

NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Nektar Therapeutics (NASDAQ: NKTR) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own NKTR please contact Justin Kuehn, Esq. by email at  jkuehn@moorekuehn.com.  There is no cost to you.  Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers.

Please visit  http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/

Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
jkuehn@moorekuehn.com  
(212) 709-8245